View Grant Opportunity
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
National Institutes of Health
PAR-25-321
HHS-NIH11
General Information
N/a
Est. Program Funding:
Est. Program Funding:
January 7, 2028
Closing Date:
Closing Date:
N/a
Expected No. of Awards
Expected No. of Awards
N/a
Award Ceiling
Award Ceiling
Opportunity Number:
PAR-25-321
Owning Agency:
HHS-NIH11
Opportunity Category:
Discretionary (D)
Synopsis
| Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility. | |
| Response Date | Jan 07, 2028 12:00:00 AM EST |
| Posting Date | Dec 10, 2024 12:00:00 AM EST |
| Archive Date | Feb 12, 2028 12:00:00 AM EST |
| Award Ceiling | N/a |
| Award Floor | N/a |
| Cost Sharing | No |
Eligibility
| Eligible Applicants | Native American tribal organizations (other than Federally recognized tribal governments), County governments, Public and State controlled institutions of higher education, State governments, Private institutions of higher education, For profit organizations other than small businesses, City or township governments, Native American tribal governments (Federally recognized), Independent school districts, Special district governments, Public housing authorities/Indian housing authorities, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Small businesses, Others (see text field entitled "Additional Information on Eligibility" for clarification) |
| Additional Info on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name | National Institutes of Health |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-25-321.html |
| Grantor Contact Information: |
If you have difficulty accessing the full announcement electronically, please contact:
GrantSolutions Help Desk Phone: 301-402-2541 |
CFDA Program(s)
- 93.393: Cancer Cause and Prevention Research
- 93.394: Cancer Detection and Diagnosis Research
- 93.395: Cancer Treatment Research
- 93.396: Cancer Biology Research
- 93.399: Cancer Control
Contact Us
Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.